A randomized, phase III trial of paclitaxel plus carboplatin (TC) versus paclitaxel plus cisplatin (TP) in stage IVb, persistent or recurrent cervical cancer: Japan Clinical Oncology Group study (JCOG0505).
Ryo Kitagawa
No relevant relationships to disclose
Noriyuki Katsumata
No relevant relationships to disclose
Taro Shibata
No relevant relationships to disclose
Toru Nakanishi
No relevant relationships to disclose
Sadako Nishimura
No relevant relationships to disclose
Kimio Ushijima
No relevant relationships to disclose
Masashi Takano
No relevant relationships to disclose
Toyomi Satoh
No relevant relationships to disclose
Hiroyuki Yoshikawa
No relevant relationships to disclose
Toshiharu Kamura
No relevant relationships to disclose